Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 25 min ago

Oncology

5,305 studies560 in 7 days2,549 in 30 days

Filters
Type
Date
Clear

Latest

5,305 studies

  1. Effect modification of gallbladder wall thickness on the association between fibrosis-4 index and high-risk colorectal adenoma in patients with gallbladder polyps: a retrospective cross-sectional study.
    Wenting Xu, Shuang Chen, Lihong Wang
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  2. Global, regional and national cancer burden and trends of middle-aged and older populations: a GBD 2021-based analysis, prediction and prevention.
    Ruokai Sun, Feng Shi, Yinsi Tang +5
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  3. Calendar-defined missed-workday gaps in radiotherapy: a site- and phase-stratified audit with linkage sensitivity analyses.
    Runhong Lei, Yongping Zheng, Yi Chen +3
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. Sequential patient-spouse dyadic psychological intervention for perioperative emotional distress and dyadic coping in patients with spinal metastases.
    Liping Xie, Yunli Wang, Zhixiao Wang +9
    Frontiers in public healthPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  5. Blood-based inflammatory biomarkers in ovarian cancer: addressing the challenge of early detection, metastasis, and prognostic stratification.
    Emmanuel Ifeanyi Obeagu
    Oncology reviewsPeer-reviewedCC BYFull textOncologyEurope PMC
  6. A CAR/CD19 Jurkat cell model for bioprocess screening and expansion: potential use for CAR-T cells production.
    Hugo E Fuentes-Bustos, Alejandrina Hernández-López, Marta Zapata-Tarrés +4
    Frontiers in bioengineering and biotechnologyPeer-reviewedCC BYFull textOncologyEurope PMC
  7. Ultra-high-dose-rate pulsed irradiation and the conditional FLASH effect: dosimetry, multiscale biology, and clinical translation.
    Jincheng Zhang, Hao Lu, Guofu Dong +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  8. Clinicopathologic characteristics and diagnostic value of PD-L1 in immune checkpoint inhibitor-related liver injury: a single-center retrospective study.
    Huaying Lai, Xinyan Zhao, Dongmei Zhou +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  9. Optimizing exercise regimens for quality of life in patients with cancer: a network meta-analysis and dose-response study.
    Zhengxin Hui, Liang Li, Yinping Zhang +1
    BMC cancerPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCDOAJ
  10. LASSO-based nomogram to predict early treatment failure in advanced hepatocellular carcinoma treated with SBRT, lenvatinib, and tislelizumab.
    Yingchun Zhao, Suming Wang, Li He +3
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  11. Pembrolizumab-induced fulminant type 1 diabetes mellitus: a case report and literature review.
    Shujun Sun, Liang Su, Xiaojing Ma +1
    Frontiers in endocrinologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  12. From etiology to precision oncology: a systematic review of the causes and evolving treatments of prostate cancer.
    Nakitto Irene Kisakye, Geoffrey Ayebazibwe, Paula Mary Amito +10
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  13. InDuRanS: neoadjuvant immunochemotherapy followed by surgery or definitive chemoradiotherapy and consolidation durvalumab in resectable and borderline resectable stage IIB-IIIA/B non-small-cell lung cancer.
    Eleni Gkika, Cornelius F Waller, Cas S Dejonckheere +11
    Frontiers in oncologyPeer-reviewedCC BYFull text1 citedOncologyEurope PMCCrossref
  14. Confidence-based classification of clinically significant prostate cancer on biparametric MRI using Monte Carlo dropout and Grad-CAM visualization.
    Cheng Hao, Yuze Meng, Yong Peng +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  15. Frailty phenotype and long-term mortality after curative colorectal cancer surgery: a retrospective multicenter cohort study.
    Yuxiao Xia, Minghui Li, Yuanling Zeng +7
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  16. A surprising complete radiographic response to palbociclib plus endocrine therapy in an HR-positive, HER2-low lung, pleural, and lymph node metastatic breast cancer patient: a case report.
    Mingzhi Cha, Hao Yi, HuiMing Li +1
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  17. Case Report: Fatal varicella-zoster virus meningoencephalitis with Froin-like cerebrospinal fluid and hydrocephalus following pembrolizumab-containing chemoimmunotherapy.
    Fangfang Shen, Siyuan Fan, Yanyan Wang +2
    Frontiers in pharmacologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  18. A prospective pilot study of urine microRNA as a biomarker of urinary radiation toxicity following MRI-guided prostate stereotactic body radiotherapy.
    Urszula Smyczyńska, Zuzanna Nowicka, Patrick Doyle +7
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  19. Outcomes for American Indian and Alaska Native Populations With Cancer in Traditional Medicare
    T. Anders Olsen, Matthew Tobey
    JAMA Network OpenPeer-reviewedCC BY 4.0OncologyCrossref
  20. What Medicare Claims Tell Us About Cancer Disparities in American Indian and Alaska Native Peoples
    Cole Allick, Denise A. Dillard
    JAMA Network OpenPeer-reviewedCC BY 4.0OncologyCrossref
  21. Predictive value of monocyte-to-HDL and neutrophil-to-HDL cholesterol ratio for obstructive coronary artery disease in Patients undergoing coronary angiography.
    Dania A Bani Hani, Jafar A Alshraideh, Afaf S Yousef +6
    American heart journal plus : cardiology research and practicePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  22. IL18BP in cancer: a double-edged sword and emerging therapeutic opportunity
    Chenshen Huang, Yiqing Jiang, Ning Wang +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  23. Beyond immune surveillance: IFN-γ and PD-L1 as shapers of tumor plasticity in Non-Small Cell Lung Cancer (NSCLC)
    Stefania Angelicola, Mariateresa Frascino, Ilaria C. Chillico +10
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  24. Chemokines as regulators of CAR-T cell trafficking, function, and context-dependent tumor cell death
    Ksenia Levchuk, Alexey Petukhov, Shynggys Tursymbek +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  25. HIV-associated extranodal NK/T cell lymphoma, nasal type: a case report and literature review
    Junjie Wang, Lingyao Du, Tian Dong +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC